Loading...

Insulet Corporation

PODDNASDAQ
HealthcareMedical - Devices
$323.20
$-1.80(-0.55%)

Insulet Corporation PODD Peers

See (PODD) competitors and their performances in Stock Market.

Peer Comparison Table: Medical - Devices Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
PODD$323.20-0.55%22.7B58.13$5.56N/A
ABT$133.70+0.10%232.6B17.39$7.69+1.71%
BSX-PA$122.18+2.37%175.4B230.53$0.53N/A
BSX$103.09-1.04%152.5B75.25$1.37N/A
SYK$380.93+0.02%145.6B51.62$7.38+0.86%
MDT$85.53+2.14%109.7B23.69$3.61+3.28%
EW$77.72-0.48%45.6B32.12$2.42N/A
DXCM$86.77+1.47%34B65.24$1.33N/A
STE$243.27+0.49%23.9B39.56$6.15+0.92%
PHG$22.80-0.04%21.1B78.62$0.29+3.88%
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

PODD vs ABT Comparison

PODD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PODD stands at 22.7B. In comparison, ABT has a market cap of 232.6B. Regarding current trading prices, PODD is priced at $323.20, while ABT trades at $133.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PODD currently has a P/E ratio of 58.13, whereas ABT's P/E ratio is 17.39. In terms of profitability, PODD's ROE is +0.35%, compared to ABT's ROE of +0.31%. Regarding short-term risk, PODD is more volatile compared to ABT. This indicates potentially higher risk in terms of short-term price fluctuations for PODD.

Stock Price Comparison

Loading...

Frequently Asked Questions